Search

Your search keyword '"Ahrén C"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Ahrén C" Remove constraint Author: "Ahrén C"
147 results on '"Ahrén C"'

Search Results

4. Results of Screening, Rescreening, and Follow-up in a Prospective Randomized Study for Detection of Colorectal Cancer by Fecal Occult Blood Testing: Results for 68,308 Subjects

5. [Clothes in health care. Don't mix identification and hygiene routines]

6. Epidemiologie von MRSA und aktuelle Präventionsstrategien in Europa und Japan

17. Functional and structural studies of ileal reservoirs used for continent urostomy and ileostomy.

18. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.

19. NUCLEAR SHAPE VARIATIONS IN THE FASCICULAR ZONE OF THE RAT ADRENAL GLAND

20. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease

21. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?

22. Experimental enterotoxin-induced Escherichia coli diarrhea and protection induced by previous infection with bacteria of the same adhesin or enterotoxin type

23. Synergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens

24. Nonimmunoglobulin fraction of human milk inhibits bacterial adhesion (hemagglutination) and enterotoxin binding of Escherichia coli and Vibrio cholerae

25. Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood.

26. Comparison of methods for detection of colonization factor antigens on enterotoxigenic Escherichia coli

29. Presence of colonization factor antigens on fresh isolates of fecal Escherichia coli : a prospective study.

30. Infection with Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus t034.

34. Evaluation of anamnestic criteria for the identification of patients with acute community onset viral gastroenteritis in the emergency department--A prospective observational study.

35. Notification card to alert for methicillin-resistant Staphylococcus aureus is stigmatizing from the patient's point of view.

36. Sub-typing of extended-spectrum-β-lactamase-producing isolates from a nosocomial outbreak: application of a 10-loci generic Escherichia coli multi-locus variable number tandem repeat analysis.

37. Virulence gene typing of methicillin-resistant Staphylococcus aureus as a complement in epidemiological typing.

38. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs.

39. Effective control measures limited measles outbreak after extensive nosocomial exposures in January-February 2008 in Gothenburg, Sweden.

40. Proposal for common Nordic epidemiological terms and definitions for methicillin-resistant Staphylococcus aureus (MRSA).

41. [If good hand hygiene routines are not followed no private rooms in the world will help].

42. The impact of active intervention on the spread of penicillin-resistant Streptococcus pneumoniae in Swedish day-care centres.

43. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.

44. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.

45. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.

46. Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses.

47. Plasma nitrate as an index of nitric oxide formation in patients with acute infectious diseases.

48. Mucosal antibodies can be measured in air-dried samples of saliva and feces.

49. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine.

50. Optimization of the intestinal lavage procedure for determination of intestinal immune responses.

Catalog

Books, media, physical & digital resources